Difficulty: Medium
Average Score: 69%
Practice
The strong antiemetic effect of the phenothiazine derivatives is due to dopamine receptor blockade:
Correct answer
A
Rationale
In the context of advanced pharmacology across the lifespan, understanding the mechanism of action of medications is crucial for safe and effective prescribing. In this case, the question pertains to the strong antiemetic effect of phenothiazine derivatives, which is primarily due to dopamine receptor blockade.
Option A, "In the chemoreceptor trigger zone of the medulla," is the correct answer. The chemoreceptor trigger zone (CTZ) in the medulla is a key area in the brain where signals inducing vomiting are received. By blocking dopamine receptors in the CTZ, phenothiazine derivatives are able to effectively prevent nausea and vomiting.
Options B and C are incorrect. Blocking dopamine receptors in the stomach (Option B) would not have a significant antiemetic effect, as the primary site of action for antiemetic drugs is within the central nervous system. Similarly, while dopamine receptors in the medullar vomiting centre (Option C) may play a role in regulating vomiting, the CTZ is the more specific target for antiemetic therapy.
Educationally, this question highlights the importance of understanding the precise mechanisms of action of medications to achieve desired therapeutic outcomes. By targeting specific receptors in the brain like those in the CTZ, healthcare providers can select the most appropriate antiemetic agents for patients experiencing nausea and vomiting. This knowledge is especially valuable in the care of patients across the lifespan, where individual differences in drug responses must be carefully considered.
Option A, "In the chemoreceptor trigger zone of the medulla," is the correct answer. The chemoreceptor trigger zone (CTZ) in the medulla is a key area in the brain where signals inducing vomiting are received. By blocking dopamine receptors in the CTZ, phenothiazine derivatives are able to effectively prevent nausea and vomiting.
Options B and C are incorrect. Blocking dopamine receptors in the stomach (Option B) would not have a significant antiemetic effect, as the primary site of action for antiemetic drugs is within the central nervous system. Similarly, while dopamine receptors in the medullar vomiting centre (Option C) may play a role in regulating vomiting, the CTZ is the more specific target for antiemetic therapy.
Educationally, this question highlights the importance of understanding the precise mechanisms of action of medications to achieve desired therapeutic outcomes. By targeting specific receptors in the brain like those in the CTZ, healthcare providers can select the most appropriate antiemetic agents for patients experiencing nausea and vomiting. This knowledge is especially valuable in the care of patients across the lifespan, where individual differences in drug responses must be carefully considered.